• Nenhum resultado encontrado

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.

N/A
N/A
Protected

Academic year: 2017

Share "MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs."

Copied!
16
0
0

Texto

Loading

Imagem

Table 1. Differentially expressed miRNAs in ccRCC as compared with adjacent normal tissues.
Fig 1. MiRNA expression profiling in ccRCC using microarray analysis. Unsupervised clustering of differentially expressed miRNAs in the three stages of ccRCC tumors (GI, GII and GIII) as compared with adjacent normal tissues
Fig 2. MicroRNA-gene network in ccRCC. (A) The top 10 Gene Ontology terms significantly enriched by predicted target genes of the up-regulated (A1) and down-regulated (A2) miRNAs in ccRCC
Table 3. Candidate target genes of miR-199a-5p and the inserted sequences in psiCHECK vectors.
+3

Referências

Documentos relacionados

The renal carcinoma has multiple aspects and although one can find tumours consisting of a single cell type, most often they are associated with different areas, with

We investigated the levels of expression of 12 circulating miRNAs (c-miRNAs) involved in cell proliferation, differentiation, angiogenesis, inflammation and

Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients. The value of the pretreatment albumin/globulin ratio in predicting the

Quinze (93.7%) dos 16 sujeitos com obesidade não mórbida não referem qualquer tipo de experiência adversa durante a infância; sendo que mais de metade (64.2%) dos

However, our research provides useful data for diagnosis of RCC: we demonstrated that miRNA-378 is highly ex- pressed in the plasma of cancer patients, it can be used to distinguish

Sequential therapy with targeted agents in patients with advanced renal cell carcinoma: optimizing patient benefit.. [Renal cell carcinoma-response criteria of molecular

Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the

The atypical expression of GLUTs in oral squamous cell carcinoma does not necessarily signify an increase in the rate of glucose transport to the tumor cell, in order to promote